Citadel Advisors’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$298K Buy
9,900
+2,000
+25% +$64.7K ﹤0.01% 10483
2025
Q4
$274K Buy
7,900
+1,300
+20% +$45.9K ﹤0.01% 10344
2025
Q3
$240K Sell
6,600
-26,900
-80% -$914K ﹤0.01% 10856
2025
Q2
$1.05M Buy
33,500
+25,800
+335% +$801K ﹤0.01% 6974
2025
Q1
$228K Sell
7,700
-2,000
-21% -$60K ﹤0.01% 10188
2024
Q4
$286K Sell
9,700
-9,000
-48% -$285K ﹤0.01% 9751
2024
Q3
$582K Buy
18,700
+600
+3% +$21.8K ﹤0.01% 7943
2024
Q2
$613K Buy
18,100
+11,200
+162% +$571K ﹤0.01% 7624
2024
Q1
$449K Sell
6,900
-3,300
-32% -$226K ﹤0.01% 8623
2023
Q4
$697K Buy
10,200
+9,200
+920% +$478K ﹤0.01% 7409
2023
Q3
$51.9K Buy
+1,000
New +$59.2K ﹤0.01% 11720
2023
Q2
Sell
-1,000
Closed -$49.4K 14763
2023
Q1
$49.4K Sell
1,000
-5,100
-84% -$287K ﹤0.01% 12161
2022
Q4
$348K Sell
6,100
-9,300
-60% -$523K ﹤0.01% 8990
2022
Q3
$723K Buy
15,400
+100
+0.7% +$4.77K ﹤0.01% 7692
2022
Q2
$571K Buy
+15,300
New +$497K ﹤0.01% 8340

Other funds holding IMCR